Differential effects of palmitoleic acid on human lymphocyte proliferation and function by M. E. P. Passos et al.
RESEARCH Open Access
Differential effects of palmitoleic acid on
human lymphocyte proliferation and
function
M. E. P. Passos1*, H. H. O. Alves1, C. M. Momesso1, F. G. Faria1, G. Murata2, M. F. Cury-Boaventura1, E. Hatanaka1,
S. Massao-Hirabara1 and R. Gorjão1*
Abstract
Background: Palmitoleic acid (PA) is a n-7 monounsaturated fatty acid (MUFA) secreted by adipose tissue and
related to decreased insulin resistance in peripheral tissues. Evidences have been shown that PA also decreased
proinflammatory cytokine expression in cultured macrophages. Although studies have shown that other fatty acids
(FAs) modulate several lymphocyte functions, the specific effect of PA on these cells is unknown. The aim of the
present study was to evaluate the possible influence of PA on activation and differentiation of human lymphocytes
in comparison to oleic acid (OA).
Methods: Human lymphocytes were isolated from peripheral blood of health men and cultured in the presence of
growing concentrations of PA or OA (5 to 200 μM), for 24 h. After that, cells were collected and cytotoxicity
evaluated by flow cytometry. Then, we analyzed proliferative capacity in lymphocytes treated with non toxic
concentrations of PA and OA (25 and 50 μM, respectively), in the presence or absence of concanavalin A (ConA).
The Th1/Th2/Th17 cytokine production was determined by the Cytometric Bead Array. CD28 and CD95 surface
expression and T regulatory cell percentage were determined by flow cytometry.
Results: We observed that PA is toxic to lymphocytes above 50 μM. PA promoted a decrease of lymphocyte
proliferation stimulated by ConA in both concentrations. PA also decreased CD28 externalization and increased
CD95. On the other hand, OA did not alter these parameters. In the same way, PA reduced IL6, IFN-gamma,
TNF-alpha and IL17A production in both concentration and IL2 only at 50 μM (in the presence of ConA). OA
promoted IFN-gamma reduction in both concentrations and an increase of IL-2, IL4 and IL10 at 25 μM. Both fatty
acids decreased the percentage of T regulatory cells.
Conclusion: In conclusion, PA promoted a suppressive effect on lymphocyte proliferation characterized by a
decrease of Th1 and Th17 response, and co-stimulatory molecule (CD28). However, OA increased lymphocyte
proliferation through IL2 production and Th2 response. These results also show a more suppressive effect of PA on
lymphocytes in comparison to OA.
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Background
Currently, it is well known that fatty acids (FAs) modu-
late leukocyte function. Monounsaturated FAs are con-
sidered less toxic to lymphocytes when compared to
polyunsaturated fatty acids [1]. The influence of FAs in
the control of inflammatory processes has been studied
due to the ability of these compounds to be incorporated
into the cell membranes, resulting in the production of
eicosanoids with lower inflammatory effects [2, 3]. FAs
also can bind in membrane receptors or change intracellu-
lar protein activation generating alterations in cellular
function. Some fatty acids modulate the toll like receptor-
4 induced signaling pathways promoting alterations in
inflammatory process [4] Studies have shown that mono-
unsaturated FAs modulate important transcription factors
involved with inflammatory pathways such as NF-kB [5].
The different types of FAs in the diet can modulate the
lymphocyte proliferative capacity and cytokine produc-
tion. Th1 cells are more sensitive to the effects of FAs
when compared to Th2 lymphocytes [6].
The monounsaturated FAs have different effects on the
organism, as demonstrated by studies that replaced satu-
rated FAs by monounsaturated FAs of the diet [7, 8].
Previous studies of our group showed that the oleic acid
(OA) stimulates cell proliferation in low concentrations
(12.5 and 25 μM) and decreases the proliferation in higher
concentrations (above 75 μM) [9]. In contrast, supple-
mentation with olive oil in vivo, which is rich in OA,
promotes a decrease of lymphocyte proliferation stimu-
lated with Concanavalin A (ConA) [10]. Linos et al.
[11] also observed that the supplementation with olive
oil presents a beneficial effect on the exacerbated in-
flammatory response in patients with rheumatoid arth-
ritis, due to an immunosuppressive effect.
Macadamia oil presents a higher proportion of pal-
mitoleic acid (PA) when compared to other oils. Sup-
plementation with this oil promotes a decrease of serum
triglyceride and cholesterol levels, as well as it can be
related to the reduced risk of cardiovascular diseases
development [12]. Other studies have shown that macada-
mia oil normalizes levels of HDL and LDL-cholesterol in
individuals with hypercholesterolemia [13, 14].
In addition to the diet, PA also is produced and released
by adipose tissue [15]. This FA is synthesized in adipose
tissue by the stearoyl-coenzyme A (SCD), an enzyme that
desaturates palmitic acid (16: 0) to palmitoleic acid (16:1)
[16]. It has been demonstrated that PA is related to the
increased insulin sensitivity in the liver and muscle [15],
and improved hyperglycemia and hypertriglyceridemia
through increasing insulin sensitivity and altering liver
lipid metabolism in diabetic rats [17, 18]. Bolsoni et al.
[19] demonstrated that PA also increased lipolysis and de-
creased the lipogenesis in adipocytes. Evidences have been
shown that PA also decreased NF-kB p65 phosphorylation
and proinflammatory cytokine expression in cultured
macrophages [5]. These results are indicative of pos-
sible anti-inflammatory effects promoted by PA. Plasma
PA concentration can be altered in other physiological
conditions. Tepisc et al. [20] observed an increase of PA
in plasma of professional football and basketball players
compared to sedentary human of the same age, but the
consequences of these differences are not known.
The studies about PA effects have been increased in
the last years, however there are few studies showing the
influence of PA on immune system, specifically in leuko-
cytes. Since these cells are in communication with mul-
tiple tissues, including adipose tissue [21], any changes
in the levels of PA can modulate their function. There-
fore, the aim of the present study was to evaluate the
effects of PA on activation and differentiation of human
lymphocytes in comparison to OA.
Methods
Isolation of peripheral blood lymphocytes
Human lymphocytes were obtained from the peripheral
blood of males (20–45 years) with no history of chronic
inflammatory or autoimmune diseases, infections or, other
chronic diseases (diabetes and dyslipidemias). Individuals
were instructed to not perform any physical activity for
the last 24 h before blood collection. All volunteers have
signed a consent form. This study was approved by
Cruzeiro do Sul University Ethics Committee in Human
Research (Protocol CE/UCS-084/2012).
Peripheral blood lymphocytes were obtained as described
by Böyum et al. [22]. Blood was layered on Histopaque ®
1077 reagent (Sigma Chemical Co, St. Louis, MO, EUA)
and centrifuged, for 30 min at 400 g, at room temperature.
Mononuclear cells, collected from the interphase, were
incubated for 1 h at 37 °C and 95% atmospheric air 5%
CO2, under sterile conditions into a 75 cm
2 culture bottle,
containing RPMI-1640 culture medium, enriched with
2 mM glutamine, 24 mM sodium bicarbonate, 20 mM
HEPES, 10% fetal bovine serum (FBS), and antibiotics
(1000 U/mL penicillin and 1000 μg/mL streptomycin).
Monocytes adhered to the bottle were discarded. Lympho-
cytes, remained in the supernatant, were isolated by centri-
fuging at 400 g for 10 min. The cells were resuspended in
phosphate-buffered saline (PBS).
Lymphocyte culture and treatments
Lymphocytes were cultured at 1 × 106 cells per mL in all
experiments. The toxic concentration of PA in primary
culture of human lymphocytes was determined previously
to the function and cellular activation experiments.
Initially, cells were incubated with concentrations from 25
to 200 μM of PA for 24 h. The toxic concentration of OA
(50 μM) to human lymphocytes was determined previ-
ously by Cury-Boaventura et al. [1]. Cells from control
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group were treated with ethanol with a concentration of
0.05% in all experiments, which one does not have toxic
effects to human lymphocytes [23].
Determination of membrane integrity and externalization
of phosphatidylserine
Externalization of phosphatidylserine and membrane
integrity were analyzed by flow cytometry using the
FITC Annexin V/Dead Cell Apoptosis Kit (Invitrogen,
Paisley, UK) according to the method described by
Vermes et al. [24].
Cells were cultured in RPMI 1640 medium under the
same conditions described above. After 24 h of FA treat-
ments, lymphocytes were resuspended in PBS. Poster-
iorly, 500 μL of each sample were transferred to conical
tubes. The suspension was centrifuged at 400 g for
10 min and resuspended in 100 μL of annexin buffer
(Binding Buffer: 10 mM HEPES/NaOH, 140 mM NaCl
and 2.5 mM CaCl2). 5 μL of fluorescein-conjugated
annexin V (annexin V-FITC 20 μg/mL in 25 mM HEPES
- 140 mM NaCl, 1 mM EDTA, pH 7.4, and 0.1% bovine
serum albumin) were added and the cells incubated for
15 min in the dark, at room temperature. Afterwards,
1 μL of propidium iodide (PI) (100 μg/mL) and 400 μL
of buffer were added to these samples and analyzed by
flow cytometry (FACS Aria II, Becton Dickinson, CA,
USA). Ten thousand events per sample were acquired
using filters for PI and FITC fluorescence. The histo-
grams were then analyzed using the BD-Diva software
(Becton Dickinson).
DNA fragmentation in lymphocytes
DNA fragmentation was performed by flow cytometry,
according to the method described by Nicoletti et al.
[25]. Cells (5 × 105) were resuspended in 500 μL of a
hypotonic solution containing PI (50 μg/mL, 0.1% so-
dium citrate, and 0.1% Triton X-100). Cells were then
Fig. 1 Effect of palmitoleic acid on membrane integrity and phosphatidylserine externalization of lymphocytes. After treatment with 12.5 to
100 μM of PA for 24 h, lymphocytes were incubated with propidium iodide and Annexin V-FITC and analyzed by flow cytometry. Representative
dot plots related to PI (y axis) and FITC (x axis) fluorescence are shown in: a Control cells incubated only with RPMI medium; b Cells treated with
0.05% of ethanol; c Cells treated with 75 μM of PA; d Cells treated with 100 μM of PA. The values are presented in the graph below as mean ±
S.E.M. of three determinations from six experiments. *P < 0.01 versus control or ethanol
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incubated for 30 min, at 25 °C, and the fluorescence
measured as described above.
Cell proliferation assay
Cell proliferation was evaluated as described by Gorjao et
al. [9]. Briefly, lymphocytes were isolated and resuspended
in 1 mL of RPMI-1640 medium, supplemented as de-
scribed above. Afterwards, 2.5 × 105 lymphocytes per well
were cultured in 96-well microtiter plates, in 200 μL of
RPMI medium, containing non-toxic concentrations of
25 μM and 50 μM of PA or OA. Treatments with the FAs
were performed in the presence or absence of Concanava-
lin A (5 μg/mL) (Sigma Chemical Co.). After the period of
30 h, [2-14C] thymidine (1 μCi per mL) was added to the
culture medium and cells were incubated for an additional
18 h period. At the end, cells were automatically collected
using the Multiple Skatron Combi Cell Harvester (Sulfolk,
UK). The counting of incorporated radioactivity was
performed using the Beckman-LS 5000TD Counter (Beck-
man Instruments, Fullerton, CA, USA).
Analysis of CD28 and CD95 Expression on the
Lymphocyte Surface and of percentage of T regulatory
lymphocytes
After the FA treatments, in the presence and absence of
ConA for 24 h, the expression of CD95 and CD28 on
the lymphocyte surface was performed by flow cytome-
try. The cell suspension (1 × 106 cells) was centrifuged at
400 g for 10 min, followed by washing twice with PBS
containing 1% albumin. Specific antibodies conjugated
to PerCP-Cy5 (CD28) or APC (CD 95) were added to
the cell suspensions (1:20), which ones were incubated
at room temperature for 30 min, in the dark. Negative
control cells were incubated with labeled IgG antibody.
After this period, cells were washed twice with PBS and
analyzed on the flow cytometer: FACS CD28 and CD95
Fig. 2 Effect of palmitoleic acid on human lymphocyte DNA fragmentation. After treatment with 12.5 to 100 μM of PA for 24 h, cells
were stained with a buffer containing citrate, Triton X100 and propidium iodite and analyzed by flow cytometry. The percentages
correspond to the fraction of cells with fragmented DNA. Representative dot plots of the forward-light scatter (x axis) and side-light
scatter (y axis) used as indicators of cell size and granularity respectively, and histograms from PI fluorescence are shown in: a Control
cells incubated only with RPMI medium; b Cells treated with 0.05% of ethanol; c Cells treated with 50 μM of PA; d Cells treated with
75 μM of PA. The values are presented in the graph below as mean ± S.E.M. of three determinations from six experiments. *P < 0.01
versus control or ethanol
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in Aria II (Becton Dickinson, CA, USA) and BD Accuri
the CD25 (Becton Dickinson). Histograms were analyzed
using the BD Diva Software or BD C6 Sampler Accuri
Software by determining the fluorescence through the
specific filters for each fluorochrome.
Determination of percentage of regulatory T cells in total
lymphocyte culture after the FA treatments, in the pres-
ence or absence of ConA for 48 h, was performed by flow
cytometry. Cells (1 × 106 cells) were centrifuged at 400 g,
for 15 min, followed by washing twice with PBS containing
1% albumin (BSA) and resuspended in 100 μL of same buf-
fer. The determination of Treg cell percentage was per-
formed using Foxp3+Human Kit (Becton Dickinson, CA,
USA), according to manufacturer’s instructions. Briefly, the
specific antibodies anti-CD4 (FITC) and anti-CD25 (APC)
were added to the suspension of lymphocytes (1:20) and
the cells incubated at room temperature, for 30 min, in the
dark. Negative control cells were incubated with the non-
reactive labeled IgG antibody. After this period, cells were
fixed (1% formaldehyde in PBS) and incubated in buffer
containing a permeabilizing agent (Becton Dickinson), for
15 min. Subsequently, cells were washed with PBS contain-
ing 1% BSA, followed by incubation with anti-Foxp3 (PE)
antibody, during 30 min (1:20 dilution). Twenty thou-
sand events per sample were acquired by the flow cyt-
ometer BD-Accuri. Firstly, determination of CD4+ cells
was performed and, from these cells, the percentage of
CD25+/Foxp3+ cells was determined. Histograms were
then analyzed using the BD Accuri C6 Software.
Determination of cytokine production in cultured
lymphocytes: Th1, Th2 and Th17 profile
After the FA treatments, in the presence and absence of
ConA for 24 h, the measurement of TNF-α, IL-6, IL-4,
IL-2, IL-10, IFN-γ, and IL-17A concentrations in the
lymphocyte culture supernatant was performed using
the BD™ Cytometric Bead Array (CBA) Human Th1/
Th2/Th17 Cytokine kit (BD Biosciences), according to
manufacturer’s instructions. These cytokines are largely
produced by Th1, Th2, and Th17 lymphocytes.
Briefly, 25 μL of particles containing different fluorescent
beads and covered with specific antibodies for the cyto-
kines were added to 25 μL of diluted culture supernatant
and incubated for 1 h, at room temperature in the dark.
Afterwards, 25 μL of the secondary antibody conjugated to
a fluorochrome were added to the suspension, followed by
the incubated for 2 h, at room temperature. At the same
time, the standards for each cytokine were similarly used
in the absence of the samples. The particles were washed
to remove the unbound antibodies, resuspended in wash-
ing buffer and analyzed by using the BD Accuri (BD
Biosciences). The acquisition was made in BD-Accuri C6
Software and the cytokine concentrations determined
using the FCAP Software v.3.0 (BD, Biosciences).
Statistical analysis
For statistical analysis of toxicity tests, the One-way
ANOVA test followed by Tukey’s post-test was applied,
considering significant differences when p < 0.05. For
statistical analysis of the experiments performed in the
presence or absence of ConA, the Two-way ANOVA
test followed by Bonferroni post-test was performed,
considering significant differences when p < 0.05. Statis-




In the evaluation of membrane integrity and phosphati-
dylserine externalization assays, PA promoted loss of
72% of membrane integrity in lymphocytes treated dur-
ing 24 h at 100 μM (Fig. 1). For analysis of lymphocyte
DNA fragmentation (Fig. 2), we observed that PA in-
duced an increase of 20% of DNA fragmentation in
concentrations higher than 50 μM, when compared
to control and ethanol. These results are indicative
that PA is toxic to lymphocytes in concentration
above 50 μM.
Evaluation of lymphocyte proliferative capacity
Evaluation of PA effect on lymphocyte proliferation in
non-toxic concentration is important to identify pos-
sible immunosuppressive effects of this fatty acid. In re-
lation to this parameter, PA decreased around 50% the
ConA-stimulated lymphocyte proliferation in both con-
centrations evaluated (25 and 50 μM). On the other
hand, the treatment with OA increased 17% lympho-
cyte proliferative capacity at the concentration of
25 μM, in the presence of ConA (Fig. 3). These results
are indicative that PA has immunosuppressive effects
that are not related to its toxicity.
Fig. 3 Effect of palmitoleic acid (PA) and oleic acid (OA) at
non-toxic concentration on Concanavalin A induced human
lymphocyte proliferation. After treatment with 25 and 50 μM of
PA or OA in the presence or absence of ConA for 30 h, cells were
incubated with 2 [14C]-thymidine (1 μCi/mL). Afterwards, cells
were collected and radioactivity counted. Data are expressed as counts
per minute (cpm) and presented as mean ± S.E.M. of six determinations
from six experiments. *P< 0.05 versus control. ♦P< 0.05 versus 25 μM
of PA
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Evaluation of CD28 and CD95 expression on lymphocyte
surface
Determination of molecules related to lymphocyte ac-
tivation or suppression is important to evaluate the
impact of PA on these cells. OA treatment did not
induce any change in the CD28 expression. The treat-
ment with PA promoted a decrease of 41.2 and 19%
in the expression of CD28 at both concentrations
evaluated (25 and 50 μM, respectively) when com-
pared to the control cells and a decrease of 36 and
9% when compared to cells treated with 25 and
50 μM of OA (Fig. 4).
Cells treated with PA increased 105 and 130% the ex-
pression of CD95 at 25 and 50 μM, respectively, in rela-
tion to control cells. CD95 expression in cells treated
with PA was 24.2 and 111% higher in relation to OA
treated cells with 25 and 50 μM. OA treatment did not
affect CD95 expression in lymphocytes (Fig. 5).
Evaluation of Treg cell percentage of (CD4+, CD25+,
Foxp3+)
Determination of Treg cell differentiation is important
due to the inhibitory effect of these cells on lymphocyte
proliferation control. Treatment with PA reduced the
amount of Treg cells from 3.53 to 0.22 and to 0.19% of
CD4+ cells when compared to the control cells at 25
and 50 μM, respectively (Fig. 6). Surprisingly, OA also
decreased the percentage of Treg cells from 3.53 to
0.20 and to 0.17% of CD4+ cells at 25 and 50 μM
respectively, when compared to the control cells. This
results are indicative that both FAs evaluated can
modulate Treg cell differentiation. However, the final
Fig. 4 Effect of palmitoleic acid (PA) and oleic acid (OA) at non-toxic concentration on human lymphocyte CD28 membrane surface expression. Cells
were incubated with 25 and 50 μM of PA or OA in the presence or absence of ConA for 24 h. After, cells were stained with anti- PerCP-Cy5- CD28 and
analyzed by flow cytometry. Negative controls were incubated with non-reactive IgG. Representative dot plots of the forward-light scatter (x axis) and
side-light scatter (y axis) used as indicators of cell size and granularity respectively, and histograms from PerCP-Cy5 fluorescence (related to CD28
detection) are shown in: a Negative controls; b ConA stimulated control cells; c 25 μM PA + ConA treated cells; d 25 μM OA+ ConA treated cells.
The values are presented in the graph below as mean ± S.E.M. of three determinations from six experiments. *P < 0.01 versus control. ♦P < 0.05 versus
25 μM of OA. •P < 0.05 versus 50 μM of OA
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effect of these two FAs is different as observed in
proliferation data.
Evaluation of cytokine concentrations in cell supernatant
Th1, Th2 and Th17 cytokine secretion by stimulated
lymphocytes treated with non-toxic PA or OA concen-
tration was evaluated.
Cells treated with 50 μM of PA presented a reduction of
around 64% in the production of IL-2 compared to the
cells treated with 50 μM of OA and to the control cells, in
the presence of ConA. OA increased 25 and 20% IL-2 pro-
duction at 25 μM when compared to the control and PA
(25 μM) groups, respectively (Fig. 7). Cells treated with PA
in both concentrations (25 and 50 μM) presented a reduc-
tion in the production of IL-6 (90 and 81.8% respectively)
when compared to the control group. In the comparison
to OA group, PA treated lymphocytes presented 93.6 and
87.1% lower secretion of this cytokine at 25 and 50 μM,
respectively. We also observed a reduction of 83.3 and
93.3% in the production of IFN-γ when the cells were
treated with PA at 25 and 50 μM when compared to con-
trol group (Fig. 7). The treatment with OA also promoted
a decrease of 40 and 50% of IFN-γ secretion in relation to
control group.
TNF-alpha production was reduced 23.6 and 47.4% by
the treatment with PA at 25 and 50 μM respectively, in
comparison to control cells. The decrease induced by
the treatment with 50 μM of PA was 47% lower when
compared to the treatment with 50 μM of OA (Fig. 4).
These data are suggestive that PA modulates inflam-
matory Th1 response leading to a suppression of cyto-
kines produced by these cells.
Fig. 5 Effect of palmitoleic acid (PA) and oleic acid (OA) at non-toxic concentration on CD95 human lymphocyte membrane surface expression
in. Cells were incubated with 25 and 50 μM of PA or OA in the presence or absence of ConA for 24 h. After, cells were stained with anti-APC-
CD95 and analyzed by flow cytometry. Negative controls were incubated with non-reactive IgG. Representative dot plots of the forward-light
scatter (x axis) and side-light scatter (y axis) used as indicators of cell size and granularity respectively, and histograms from APC fluorescence
(related to CD95 detection) are shown in: a Negative controls; b ConA stimulated control cells; c 25 μM PA + ConA treated cells; d 25 μM
OA + ConA treated cells. The values are presented in the graph below as mean ± S.E.M. of three determinations from six experiments.
*P < 0.01 versus control. ♦P < 0.05 versus 25 μM of OA. •P < 0.05 versus 50 μM of OA
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IL-4 production was elevated in lymphocytes treated with
25 μM of OA when compared to the PA treatment and to
the control cells (Fig. 7). PA did not alter production of IL-4.
IL-10 concentration was increased in lymphocytes treated
with 25 μM of OA in comparison to the control cells. There
were no differences between OA and PA groups at any con-
centration for this cytokine (Fig. 7). These data show data
the PA treatment did not affect Th2 response.
We also observed an IL-17A reduction in lymphocytes
treated with PA compared to control (reduction of 55.5
and 60%) and OA groups, at both concentrations (25
and 50 μM). OA promoted a reduction of 33.3% of this
cytokine only at 50 μM (Fig. 7). These results indicate
that PA and OA modulate Th17 response.
Discussion
Studies have shown that PA plasma concentration can
be modulated in several conditions and it is related to
important metabolic alterations. However, this is the first
study to show direct PA effects on lymphocytes. Firstly,
we analyzed the toxic concentration of PA on these cells.
We found that PA promotes death of lymphocytes at
concentration above 50 μM. The toxicity of PA was
similar to OA, as showed in previous studies of our
group [1, 9]. FAs, at high concentrations, can induce
leukocyte death by apoptosis or necrosis, modifying the
cell activation process. However, at low concentrations
(25 μM), OA stimulates proliferative capacity in lympho-
cytes, showing the importance of evaluate FA effects at
different non-toxic concentrations.
Therefore, we evaluated the PA effects in non-toxic con-
centrations (25 and 50 μM) on the proliferative capacity of
lymphocytes. This FA promoted a reduction in cell prolif-
eration compared to the control group, in the ConA-
stimulated condition. These results suggest that PA has a
suppressive effect on lymphocyte activation even at non-
toxic concentrations, and that this effect is different to
that observed by the OA treatment.
Lymphocytes activation is usually modulated by expres-
sion of co-stimulatory molecules on the cell membrane and
Fig. 6 Effect of palmitoleic acid (PA) and oleic acid (OA) at non-toxic concentration on T regulatory cell differentiation. Cells were incubated with 25
and 50 μM of PA or OA in the presence or absence of ConA for 24 h. After, cells were stained with anti-CD4 (FITC) and anti-CD25 (APC). The negative
control cells were incubated with non-reactive labeled antibody IgG. After this period, the cells were fixed and incubated in buffer containing a
permeabilizing agent followed by incubation with anti-Foxp3 (PE). Twenty thousand events in CD4+ cells per sample were acquired in histograms
on the flow cytometer BD-Accuri. At first, a determination of CD4+ cells was performed and from these, the percentage of CD25 + Foxp3 + cells was
determined. Representative dot plots of APC fluorescence (x axis) and PE fluorescence (y axis) used as indicators of CD25 and Foxp3 are shown in: a
Control cells; b ConA stimulated control cells; c 50 μM PA treated cells; d 50 μM PA + ConA treated cells; e 50 μM OA treated cells; f 50 μM OA+ ConA
treated cells The values are presented as mean ± S.E.M. of three determinations from six experiments. *P < 0.01 versus control
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by the action of several cytokines. Cytokines play a crucial
role in controlling the expansion of T cells during immune
response to pathogenic antigens. Cytokines also regulate
the processo of differentiation of these cells, depending of
the required response [26–29]. We determined the concen-
trations of several cytokines released by lymphocytes into
the culture supernatant under different conditions.
We found that PA reduced IL6, IFN-γ, TNF-α, and
IL17A content at both concentrations evaluated, and
IL-2 level only at 50 μM. These cytokines exhibit in-
flammatory characteristics, leading to lymphocyte acti-
vation, mainly addressing a Th1 and Th17 response.
The effects of PA on cytokine production can be in-
volved with the suppressive role of this FA on
lymphocyte proliferation. We also observed that OA
promoted a reduction of IFN-γ content at both con-
centrations and an increase of IL-2, IL-4, and IL-10
levels at 25 μM. The IL-2 cytokine is essential for
stimulating cell proliferation [9] and it can be a pos-
sible pathway involved in the OA effect on the activa-
tion of cell proliferation at 25 μM. Additionally, IL-4
and IL-10 induced a Th2 response, which one would
be specific for reactions related with hypersensitivity.
Therefore, reduction in Th1 and Th17A cytokine release
by the PA treatment was not associated with Th2 response.
In addition to the modulation of cytokine production
by PA, this FA can influence peripheral activation of
lymphocytes. We analyzed the percentage of Treg cells
(CD4+/CD25+/Foxp3+), which one exhibits suppressive
characteristics. We found that both PA and OA pro-
moted a reduction in the percentage of these cells in
both concentrations when compared to control cells.
Treg lymphocytes reduce the clonal expansion of Th1
and Th17A cells and, consequently, decreasing the in-
flammatory response [30, 31]. However, in the present
study, PA inhibited proliferative capacity of lymphocytes
and the production of inflammatory cytokines (Th1 and
Th17 response), as well as the percentage of Treg cells.
These results suggest that the suppressor effect of PA on
lymphocyte proliferation and activation may involve dif-
ferent regulatory mechanisms. On the other hand, the
inhibitory effect of PA on IL-2 production can be related
Fig. 7 Effect of palmitoleic acid (PA) and oleic acid (OA) at non-toxic concentration on human lymphocyte cytokine production. Cells were
incubated with 25 and 50 μM of PA or OA in the presence or absence of ConA for 24 h. After, supernatant was collected and IL-2, IFN-gamma,
TNF-alpha, IL-4, IL-10, IL-6 and IL-17 concentration determined by Cytometric Bead Array. The values are presented as mean ± S.E.M. of three
determinations from six experiments. *P < 0.01 versus control. ♦P < 0.05 versus 25 μM of OA. •P < 0.05 versus 50 μM of OA
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to Treg percentage decrease, since this cytokine has
been associated to Treg cell differentiation [32].
Among the possible mechanisms involved with the
control of lymphocyte activation are the co-stimulatory
molecules on T lymphocyte surface. The interaction of
CD28 molecule with B7 at the antigen presenting T cell
is essential for lymphocyte activation, stimulating and
sustaining cell proliferation. The increased B7/CD28
interaction is associated with exacerbated development
of inflammation [33]. CD28 is stimulated in the first
steps of T cell activation and it is related to IL-2 secre-
tion, B cell proliferation and differentiation into
antibody-producing plasma cells and intensification of
proinflammatory gene expression by lymphocytes [34].
In the present study, we observed that PA reduced
CD28 expression when compared to control or OA
treated cells, at the both concentrations evaluated,
suggesting that PA is able to inhibit lymphocyte prolifer-
ation by reducing the expression of CD28 and, conse-
quently, cell activation. This effect may be related to the
decrease of inflammatory cytokines IL6, IFN-γ and
TNF-α promoted by this FA [34, 35]. In fact, CD28
binding to its ligands is associated to activation of tran-
scription factors such as NF-AT, AP-1 and NF-κB lead-
ing to expression of inflammatory cytokine genes [36].
In contrast, expression of CD95 on the cell surface
and its binding to Fas ligand (Fas L) are processes that
initiate cell apoptosis [37], leading to an arrest of cell
proliferation process. Some studies show that mutations
in genes encoding CD95 may lead to the accumulation
of peripheral lymphocyte, ultimately leading to the de-
velopment of autoimmune diseases [38]. PA increased
CD95 expression when compared to control and OA
treated cells, indicating that this FA decreases lympho-
cyte proliferation through suppressing activation mole-
cules and stimulating suppressor receptors, resulting in
a reduced Th1 and Th17 response and inhibited inflam-
matory response.
The balance of inhibitory and stimulatory signals to the
lymphocyte proliferation and activation determines the na-
ture of the T cell response. Excessive lymphocyte activation
can promote exacerbated inflammation and increase the
risk for immune disease development [39]. The suppressive
PA effect on lymphocyte proliferation ile may lead to a re-
duction in the production of inflammatory cytokines by
Th17 and Th1, characterizing a possible anti-inflammatory
effect of this FA. On the other hand, OA promoted stimula-
tory effects on lymphocyte activation maybe due to mecha-
nisms involved with IL-2 production and Th2 activation.
Conclusions
In conclusion, we found that PA has a suppressing effect
on lymphocyte activation, promoting reduction in prolif-
erative capacity. This effect is characterized by decreased
production of inflammatory cytokines involved with Th1
and Th17A cell responses. Additionally, PA reduced the
expression of activation molecule CD28 and increased
the inhibitory receptor CD95, without involving Treg
cell response. On the other hand, the stimulatory effect
of OA on cell proliferation is related to IL-2 production,
without interfering in other parameters. In summary, we
found an anti-inflammatory action of PA on lympho-
cytes. Therefore, we believe that this research can con-
tribute to the improvement of inflammatory immune
disorders treatment, but more studies in relation to PA
should be continued to achieve this goal.
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